Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

Nabil Ahmed; Vita Brawley; Meenakshi Hegde; Kevin Bielamowicz; Amanda Wakefield; Alexia Ghazi; Aidin Ashoori; Oumar Diouf; Claudia Gerken; Daniel Landi; Mamta Kalra; Zhongzhen Yi; Cliona Rooney; Gianpietro Dotti; Adrian Gee; Helen Heslop; Stephen Gottschalk; Suzanne Zein-Eldin Powell; Robert G. Grossman; Winfried Wels; Yzonne Kew; David S. Baskin; Jonathan Zhang; Pamela New; John Hicks

doi:10.1186/2051-1426-3-S2-O11

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

Nabil Ahmed, Vita Brawley, Meenakshi Hegde, Kevin Bielamowicz, Amanda Wakefield, Alexia Ghazi, Aidin Ashoori, Oumar Diouf, Claudia Gerken, Daniel Landi, Mamta Kalra, Zhongzhen Yi, Cliona Rooney, Gianpietro Dotti, Adrian Gee, Helen Heslop, Stephen Gottschalk, Suzanne Zein-Eldin Powell, Robert G. Grossman, Winfried WelsYzonne Kew, David S. Baskin, Jonathan Zhang, Pamela New, John Hicks

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Original language	English (US)
Article number	O11
Journal	Journal for immunotherapy of cancer
Volume	3
DOIs	https://doi.org/10.1186/2051-1426-3-S2-O11
State	Published - 2015

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Molecular Medicine
Oncology
Pharmacology
Cancer Research

Access to Document

10.1186/2051-1426-3-S2-O11

Cite this

Ahmed, N., Brawley, V., Hegde, M., Bielamowicz, K., Wakefield, A., Ghazi, A., Ashoori, A., Diouf, O., Gerken, C., Landi, D., Kalra, M., Yi, Z., Rooney, C., Dotti, G., Gee, A., Heslop, H., Gottschalk, S., Powell, S. Z.-E., Grossman, R. G., ... Hicks, J. (2015). Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. Journal for immunotherapy of cancer, 3, Article O11. https://doi.org/10.1186/2051-1426-3-S2-O11

Ahmed, N, Brawley, V, Hegde, M, Bielamowicz, K, Wakefield, A, Ghazi, A, Ashoori, A, Diouf, O, Gerken, C, Landi, D, Kalra, M, Yi, Z, Rooney, C, Dotti, G, Gee, A, Heslop, H, Gottschalk, S, Powell, SZ-E, Grossman, RG, Wels, W, Kew, Y, Baskin, DS, Zhang, J, New, P & Hicks, J 2015, 'Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial', Journal for immunotherapy of cancer, vol. 3, O11. https://doi.org/10.1186/2051-1426-3-S2-O11

@article{31ced524da4c4b1cbb0acddb36a5f8d7,

title = "Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial",

author = "Nabil Ahmed and Vita Brawley and Meenakshi Hegde and Kevin Bielamowicz and Amanda Wakefield and Alexia Ghazi and Aidin Ashoori and Oumar Diouf and Claudia Gerken and Daniel Landi and Mamta Kalra and Zhongzhen Yi and Cliona Rooney and Gianpietro Dotti and Adrian Gee and Helen Heslop and Stephen Gottschalk and Powell, {Suzanne Zein-Eldin} and Grossman, {Robert G.} and Winfried Wels and Yzonne Kew and Baskin, {David S.} and Jonathan Zhang and Pamela New and John Hicks",

year = "2015",

doi = "10.1186/2051-1426-3-S2-O11",

language = "English (US)",

volume = "3",

journal = "Journal for immunotherapy of cancer",

issn = "2051-1426",

publisher = "BioMed Central",

}

TY - JOUR

T1 - Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

AU - Ahmed, Nabil

AU - Brawley, Vita

AU - Hegde, Meenakshi

AU - Bielamowicz, Kevin

AU - Wakefield, Amanda

AU - Ghazi, Alexia

AU - Ashoori, Aidin

AU - Diouf, Oumar

AU - Gerken, Claudia

AU - Landi, Daniel

AU - Kalra, Mamta

AU - Yi, Zhongzhen

AU - Rooney, Cliona

AU - Dotti, Gianpietro

AU - Gee, Adrian

AU - Heslop, Helen

AU - Gottschalk, Stephen

AU - Powell, Suzanne Zein-Eldin

AU - Grossman, Robert G.

AU - Wels, Winfried

AU - Kew, Yzonne

AU - Baskin, David S.

AU - Zhang, Jonathan

AU - New, Pamela

AU - Hicks, John

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=85007303604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007303604&partnerID=8YFLogxK

U2 - 10.1186/2051-1426-3-S2-O11

DO - 10.1186/2051-1426-3-S2-O11

M3 - Article

AN - SCOPUS:85007303604

SN - 2051-1426

VL - 3

JO - Journal for immunotherapy of cancer

JF - Journal for immunotherapy of cancer

M1 - O11

ER -

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this